Chidamide, Venetoclax, Azacitidine, and Homoharringtonine for High-risk Fit AML

NCT07643636 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

46

Enrollment

OTHER_GOV

Sponsor class

Conditions

AML (Acute Myeloid Leukemia)

Interventions

DRUG: Chidamide (Chi)+VAH

Sponsor

Dongguan People's Hospital